JPRN-UMIN000002743已完成未知
Investigation for efficacy and safety of high dose chemotherapy (MEAM) supported with auto-PBSCT for malignant lymphoma (THF 13) - MEAM-auto-PBSCT-ML (THF 13)
TOHOKU HEMATOLOGY FORUM0 个研究点目标入组 30 人开始时间: 2009年11月10日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 65years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1 severe bacterial infection 2 positive test for HIV antibody 3 positive test for HBs antigen 4 positive test for HCV antibody 5 angina pectoris, myocardial infarction, treatment required arrhythmia 6 interstitial pneumonia, pulmonary fibrosis, severe pulmonary emphysema
研究者
相似试验
已完成
不适用
Safety evaluation studies of high dose intake of capsules including herb extractHealthy adultJPRN-UMIN000028987TTC Co., Ltd.10
已完成
不适用
Investigation of the efficacy and safety of high-dose clarithromycin in adult patients with community-acquired pneumonia-multicenter,single-group,open-label studyAdult community-acquired pneumoniaJPRN-UMIN000016277Department of medicine, Division of clinical infectious diseases, School of medicine, Showa university30
已完成
不适用
Safety evaluation studies of high dose intake of a food aiming for official recognition as a Food with Function Claims.Healthy volunteersJPRN-UMIN000035164Kochi University12
已完成
2 期
Clinical efficacy and safety assessment of high-dose Bevacizumab plus Fluorouracil and Leucovorin (sLV5FU2) in patients with standard chemotherapy refractory metastatic colorectal cancer. phase II multicenter trial.Metastatic colorectal cancer patients who have been either refractory to or intolerant of prior all approved standard chemotherapy.JPRN-UMIN000009802The University of Tokyo, Graduate School of Medicine. Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery25
已完成
1 期
The study of the safety and effect of high dose allopurinol in patients with severe heart failureHeart failure.IRCT2015112125171N1Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran30